|
|
Caliper Life Sciences, Inc. - Sales Analysis Snapshot
Business Description This Report provides a comprehensive Sales & Margin summary analysis for Caliper Life Sciences, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Caliper Life Sciences, Inc.. The Group's principal activity is to develop and market life science instruments and related consumables and services for use in drug discovery and development and other life sciences research. Its LabChip microfluidic solutions provide significant advances in laboratory experimentation for the pharmaceutical and biotechnology industries. The Group provides products and services spanning in vitro and in vivo pre-clinical research to enable biopharmaceutical companies to reduce costs and standardize analytical techniques. It mainly concentrates on four key areas of the pre-clinical drug discovery and development chain: biological screening; pharmacokinetics/pharmacodynamics, ADME/Tox; and drug dosage and formulation testing. The Group distributes its products direct to customers, indirect through international network of distributors and through original equipment manufacturer channels commercial partners.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|